Stocks · Healthcare · Medical - Devices
CONMED Corporation CNMD
$46.32 +0.85% Close, Oct 2, 2026 · NYSE · Market cap $1.39B
Inexpensive vs sector
Next earnings report: Oct 28, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 10 quarters (average surprise over the last four: +11.0%).
- Diluted EPS over the last four quarters was $1.85, down 47.5% year over year.
- Net debt is 4.4× EBITDA, a high level of leverage.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth27Very weak
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 37%
- EPS growth (TTM, YoY)Bottom 28%
- FCF growth (TTM, YoY)Bottom 32%
- Revenue growth, 3-year CAGRBottom 48%
- Revenue growth accelerationBottom 44%
Quality72Positive
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 24%
- Gross marginBottom 40%
- Operating marginTop 25%
- Cash conversion (OCF / net income)Top 24%
- Accruals (lower is better)Bottom 36%
- Net debt / EBITDA (lower is better)Bottom 16%
- Interest coverTop 26%
Value88Strong
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 14%
- Free-cash-flow yieldTop 8%
- EBITDA / enterprise valueTop 12%
- Sales / enterprise valueTop 19%
- P/E vs own 5-year history (lower is better)Bottom 40%
Momentum64Neutral
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 37%
- 6-month returnTop 30%
- 1-year return vs S&P 500Bottom 41%
- Distance from 52-week highTop 21%
- Trend checklist (0–4)Top 20%
Revisions27Very weak
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 36%
- Consecutive EPS beatsTop 6%
- Share of analysts rating BuyBottom 5%
- Upside to consensus price targetBottom 3%
Stability54Neutral
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 34%
- Maximum drawdown, 3 yearsBottom 48%
- Beta vs S&P 500 (lower is better)Top 28%
- Net debt / EBITDA (lower is better)Bottom 16%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 4.4% | 3.6% | ↓ |
| EPS growth (YoY) | -53.4% | -47.5% | ↑ |
| Gross margin | 54.8% | 54.8% | ↑ |
| Operating margin | 12.9% | 10.8% | ↓ |
| FCF margin | 11.2% | 9.8% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 3.6% | 4.4% | ↓ | Bottom 37% |
| EPS growth (TTM, YoY) | -47.5% | -53.4% | ↑ | Bottom 28% |
| Gross margin | 54.8% | 54.8% | ↑ | Bottom 40% |
| Operating margin | 10.8% | 12.9% | ↓ | Top 25% |
| Net margin | 4.1% | 8.3% | ↓ | — |
| Free-cash-flow margin | 9.8% | 11.2% | ↓ | — |
| Return on invested capital | 5.0% | — | Top 24% | |
| Revenue growth, 3-year CAGR | 9.5% | — | Bottom 48% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 2.67×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 4.43×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 4.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.89%
- Net buyback yield (TTM)
- 3.12%
- Shareholder yield
- 4.01%
- Share count change, 1 year
- -3.0%
- Share count change, 3-year CAGR
- -1.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 29, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 10
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +11.0%
- Average 2-day reaction, last 8
- -1.4%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $37.50
- Target vs current price
- -19.0%
- Analysts with a rating
- 21
- Share rating Buy or Strong Buy
- 33%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 29, 2026 | +24.3% | -2.4% | +13.9% | +15.5% | — |
| Apr 29, 2026 | +8.5% | -2.3% | -0.4% | -3.6% | +16.0% |
| Jan 28, 2026 | +8.3% | -2.2% | -2.0% | +16.2% | -5.3% |
| Nov 5, 2025 | +2.9% | -2.8% | -2.2% | -3.0% | -14.2% |
| Jul 30, 2025 | +1.8% | -0.3% | +6.4% | +8.8% | -3.0% |
| Apr 30, 2025 | +17.3% | -4.0% | +9.3% | +11.5% | -0.4% |
| Feb 5, 2025 | +11.7% | +1.5% | -10.7% | -21.0% | -21.5% |
| Oct 30, 2024 | +6.1% | +0.9% | +14.4% | +14.2% | +9.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | $1.38 | $1.11 | +24.3% | $343.5M |
| Apr 29, 2026 | $0.89 | $0.82 | +8.5% | $317.0M |
| Jan 28, 2026 | $1.43 | $1.32 | +8.3% | $373.2M |
| Nov 5, 2025 | $1.08 | $1.05 | +2.9% | $337.9M |
| Jul 30, 2025 | $1.15 | $1.13 | +1.8% | $342.3M |
| Apr 30, 2025 | $0.95 | $0.81 | +17.3% | $321.3M |
| Feb 5, 2025 | $1.34 | $1.20 | +11.7% | $347.9M |
| Oct 30, 2024 | $1.05 | $0.99 | +6.1% | $316.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 25.0× | 23.7× | 53th | Top 14% |
| P/E (forward) | 10.2× | — | — | — |
| EV / EBITDA | 12.1× | — | — | Top 12% |
| EV / Sales | 1.59× | — | — | Top 19% |
| Free-cash-flow yield | 9.69% | — | — | Top 8% |
| Earnings yield | 4.00% | — | — | Top 14% |
P/E over the past five years
Range 14.5× – 78.4× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -1.8%
- Earnings per share growth (TTM)
- -47.5%
- Change in P/E multiple
- +61.0%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 59
- 50-day average slope (20 days)
- +7.2%
- 200-day average slope (20 days)
- +1.1%
- Distance from 50-day average
- -3.3%
- Distance from 200-day average
- +13.2%
- RSI (14)
- 47.5
- Relative volume
- 0.72×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 46.8%
- Volatility vs own 5-year history
- 80th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.71
- Correlation with S&P 500
- 0.27
- Current drawdown from 1-year high
- -10.7%
- Maximum drawdown, 3 years
- -72.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 9, 2021 | Jun 17, 2026 | -79.5% | 1154 days | Not yet recovered |
| May 3, 2021 | Sep 13, 2021 | -15.3% | 92 days | 29 days (Oct 22, 2021) |
| Oct 12, 2020 | Nov 2, 2020 | -10.6% | 15 days | 5 days (Nov 9, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.39B
- P/E (TTM)
- 25.0
- EPS, diluted (TTM)
- $1.85
- Revenue (TTM)
- $1.37B
- 52-week range
- $31.44 – $53.66
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.01B | $1.05B | $1.24B | $1.31B | $1.37B |
| Gross profit | $568.0M | $571.2M | $676.2M | $733.0M | $725.4M |
| Operating income | $109.7M | $70.1M | $120.6M | $200.3M | $141.1M |
| Net income | $62.5M | -$80.6M | $64.5M | $132.4M | $47.1M |
| EPS (diluted) | $1.94 | -$2.68 | $2.04 | $4.26 | $1.51 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $316.7M | $345.9M | $319.4M | $343.0M | $338.6M | $373.5M | $317.0M | $343.5M |
| Net income | $49.0M | $33.8M | $6.0M | $21.4M | $2.9M | $16.7M | $13.8M | $23.1M |
| EPS (diluted) | $1.57 | $1.08 | $0.19 | $0.69 | $0.09 | $0.54 | $0.45 | $0.77 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $111.8M | $33.4M | $125.3M | $167.0M | $170.7M |
| Capital expenditure | -$14.9M | -$21.8M | -$19.0M | -$13.1M | -$19.8M |
| Free cash flow | $96.9M | $11.6M | $106.3M | $153.9M | $150.9M |
| Dividends paid | -$23.3M | -$24.0M | -$24.5M | -$24.7M | -$24.7M |
| Net share buybacks | $0 | $0 | $0 | $0 | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $37.3M
- Total assets
- $2.30B
- Total liabilities
- $1.26B
- Total debt
- $834.2M
- Net debt
- $796.9M
- Shareholders’ equity
- $1.04B
As of Jun 30, 2026 (filed Jul 29, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 15, 2025 | $0.20 | Oct 3, 2025 |
| Jun 13, 2025 | $0.20 | Jul 3, 2025 |
| Mar 14, 2025 | $0.20 | Apr 4, 2025 |
| Dec 20, 2024 | $0.20 | Jan 3, 2025 |
| Sep 16, 2024 | $0.20 | Oct 4, 2024 |
| Jun 14, 2024 | $0.20 | Jul 5, 2024 |
| Mar 14, 2024 | $0.20 | Apr 5, 2024 |
| Dec 15, 2023 | $0.20 | Jan 5, 2024 |
Short interest
- Shares sold short
- 2,137,300
- Days to cover
- 7.31
- Change vs previous report
- -5.6%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Sep 10, 2001
- 3-for-2
- Dec 1, 1995
- 3-for-2
- Dec 28, 1994
- 3-for-2